Menu

Find clinical trials for Endometrial Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Non-Small-Cell Lung Carcinoma
A woman searches for clinical trials

Endometrial Cancer trials near Houston, TX, USA:

The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial...

Enrolling
Endometrial Cancer
Biological: Lifileucel

Phase 2

Iovance Biotherapeutics

Houston, Texas, United States and 6 other locations

and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will al...

Active, not recruiting
Endometrial Cancer
Drug: RAD001 (Everolimus)
Drug: Letrozole

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States and 1 other location

To learn if chemotherapy given in combination with radiation therapy, followed by maintenance therapy, can help to control endometrial cancer...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Dostarlimab

Phase 1

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Shenandoah, Texas, United States and 65 other locations

To learn if the combination of DKN-01 and pembrolizumab can help to control advanced or recurrent endometrial cancer....

Enrolling
Endometrial Cancer
Drug: DKN-01
Drug: Pembrolizumab

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

Locations recently updated

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Houston, Texas, United States and 235 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Houston, Texas, United States and 202 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

Houston, Texas, United States and 103 other locations

and metformin can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will also be stu...

Active, not recruiting
Endometrial Cancer
Drug: Letrozole
Drug: Metformin

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States and 5 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Doxorubicin
Drug: Paclitaxel

Phase 3

Eisai
Eisai

Houston, Texas, United States and 168 other locations